Research

Research

Work in the lab ranges from basic research on cell signaling mechanisms to synthetic biology projects on gene regulation, metabolic engineering, and enzymatic biosynthesis.

Our projects have been funded by the National Institutes of Health (NIGMS), the National Science Foundation (MCB division), the U.S. Department of Energy (BETO and BER programs), and the Burroughs Wellcome Fund (CASI program).

Molecular mechanisms for specificity in cell signaling

We study the mechanisms that allow living cells to sense and respond to external signals. Cell signaling networks are highly interconnected, with signaling proteins often shared by multiple pathways. We seek to understand how signaling proteins are directed to specific targets and how cells prevent inappropriate crosstalk between pathways. Our model systems are the Wnt and PKA signaling networks, which are involved in human cell growth, differentiation, metabolism, and disease. Understanding the underlying mechanisms for specificity may allow us to design therapeutics that precisely target specific functions without affecting other connected pathways.

Our previous work has focused on scaffold proteins, which assemble multi-protein signaling complexes. We have identified new mechanisms used by scaffold proteins to direct kinase activity to the appropriate target, using a combination of quantitative biochemical approaches and cell culture studies. Current projects focus on the relationship between scaffold protein structure and function, how cells dynamically regulate scaffold protein activity, the effects of phase separation on kinase reactivity, and role of scaffold-associated phosphatases in signal processing.

CRISPR-Cas gene regulation for bacterial metabolic engineering

We seek to develop new methods to produce useful biosynthetic compounds from engineered microorganisms. Dramatic successes have been achieved by delivering new enzymatic pathways to divert host metabolism to desirable chemical products. A major emerging bottleneck is the need to balance growth and production, typically by laborious efforts to precisely tune gene expression levels for both heterologous and endogenous metabolic genes. To address this challenge, we developed a new CRISPR-Cas gene activation (CRISPRa) system that is effective in bacteria. We can perform CRISPRa together with CRISPRi gene repression to regulate multiple genes simultaneously.

Current projects focus on three main areas: (1) applying CRISPRa/i to regulate large, multi-gene expression programs for bacterial metabolic engineering, (2) developing improved tools for programmable control of gene expression in bacteria, and (3) porting our CRISPR-Cas tools to new bacteria with unique metabolic capabilities. These projects are active collaborations with the Carothers lab at UW.

Eukaryotic genome regulation

looping

The 3D structure of eukaryotic genomes plays a central role in gene regulation, and aberrant structures are now recognized to affect a wide range of diseases. However, few approaches have been developed to correct aberrant chromatin loops and positioning within the nucleus. We seek to develop methods to efficiently engineer chromatin loops using CRISPR-Cas systems that target either genomic DNA or RNA.

In collaboration with the Baker lab at UW, we developed a CRISPR Co-LOCKR switch that senses whether the complex is bound to DNA. This switching function is an important step towards efficient DNA loop formation, and current projects are directed towards implementing this system in human cells and evaluating the functional effects on gene regulation.

Biosynthetic enzymes for non-native C-H functionalization reactions

biosynthesis

Biosynthetic enzymes can be used as highly selective catalysts for chemical synthesis. However, the current scope of non-biological enzymatic reactions is narrow and engineering new enzymes remains resource and time intensive. We are exploring the use of new structure-guided methods to identify effective target sites for directed evolution, using the non-heme iron 2-oxoglutarate dependent oxygenase (Fe(II)-2OG) superfamily as a model system. This class of enzymes is adept at selectively activating and functionalizing C-H bonds on small molecule substrates, a transformation critical for practical industrial synthesis where selective catalysis is still a major challenge.